資 料4-2-➁ 令和4年度第2回安全技術調査会の審議結果について➁ (202 ページ)
出典
公開元URL | https://www.mhlw.go.jp/stf/newpage_27906.html |
出典情報 | 薬事・食品衛生審議会 薬事分科会血液事業部会(令和4年度第2回 9/14)《厚生労働省》 |
ページ画像
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
血液感染について(英国)①
Northern Ireland
BLOOD TRANSFUSION SERVICE
Discretionary:
If it is more than 21 days since last contact,
the donor had no symptoms of monkeypox and
the donor had completed any isolation period, and
the donor had been discharged from all follow-up (including
surveillance by public health),
accept.
See additional information below for donors who received vaccination.
Additional
information
MPX does not spread easily between people. Human-to-human transmission
occurs through contact with:
infectious material from skin lesions
respiratory droplets in prolonged face-to-face contact,
virus-contaminated objects such as bedding or clothing
During the 2022 multi-country outbreak, the predominance of cases among
men who have sex with men and the distribution of the MPX skin rash at
presentation, suggests MPX transmission is associated with direct contact
during sex.
Reason for Change
Contacts may have received Imvanex, a third generation Smallpox vaccination,
to reduce the risk of serious illness. Imvanex is a live attenuated nonreplicating vaccination. For donor selection purposes this should be assessed
as a non-live vaccine. Recipients of Imvanex are eligible to donate once they
satisfy the requirements of the discretionary entry above.
New entry
420